Vaccines, blood, antisera, toxins and cultures in   Bermuda

Exports In 2022, Bermuda exported $2.76M in Vaccines, blood, antisera, toxins and cultures, making it the 89th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 5th most exported product in Bermuda. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Bermuda are: Canada ($2.76M), Trinidad and Tobago ($480), Ireland ($47), and Denmark ($32).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Bermuda between 2021 and 2022 were Canada ($2.76M), Ireland ($47), and Denmark ($32).

Imports In 2022, Bermuda imported $2.99M in Vaccines, blood, antisera, toxins and cultures, becoming the 178th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 65th most imported product in Bermuda. Bermuda imports Vaccines, blood, antisera, toxins and cultures primarily from: United Kingdom ($1.71M), United States ($602k), Costa Rica ($141k), Germany ($115k), and France ($114k).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Bermuda between 2021 and 2022 were Costa Rica ($72.5k), South Korea ($39.3k), and Belgium ($26.5k).